首页> 外国专利> METHENAMINE HYDRO SULPHOCYANATE APPLICATION FOR THE PRODUCTION OF DRUGS FOR INFECTIONS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)

METHENAMINE HYDRO SULPHOCYANATE APPLICATION FOR THE PRODUCTION OF DRUGS FOR INFECTIONS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)

机译:甲硫氨酸加氢氰酸盐在生产耐甲氧西林金黄色葡萄球菌(MRSA)感染药物中的应用

摘要

Invention herewith described refers to the methenamine hydro sulphocyanate application for the production of drugs for infections caused by methicillin-resistant staphylococcus aureus (MRSA). The therapeutic effect is achieved due to the circumstances that methenamine hydro sulphocyanate applied as a drug starts "the immunity thunderstorm" – the state of the immunity system which is characterized by an increased intensity of cellular as well as humoral components of the immune response. In such a state, MRSA partially damaged by synergic action of formaldehyde as the degradation product of methenamine and sulphocyanate ion, becomes recognizable for the immune system and is more intensively exposed to the specific defense mechanisms, which lead to the desired therapeutic effect.
机译:此处描述的发明涉及用于生产由耐甲氧西林的金黄色葡萄球菌(MRSA)引起的感染的药物的二甲基苯胺硫酸氢氰酸酯的应用。由于以下情况达到了治疗效果:作为药物使用的甲基苯二甲磺酸氢氰酸盐开始“免疫雷暴”。免疫系统的状态,其特征在于免疫反应的细胞以及体液成分的强度增加。在这种状态下,MRSA被作为二甲基亚胺和硫氰酸根离子降解产物的甲醛的协同作用部分破坏,对免疫系统变得可识别,并且更强烈地暴露于特定的防御机制,这导致了所需的治疗效果。

著录项

  • 公开/公告号RS20140001A1

    专利类型

  • 公开/公告日2015-08-31

    原文格式PDF

  • 申请/专利权人 SAVIĆIVICA;SAVIĆ IVICA;

    申请/专利号RS2014P000001

  • 发明设计人

    申请日2013-12-30

  • 分类号A61K31/095;

  • 国家 RS

  • 入库时间 2022-08-21 15:13:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号